Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia

Journal of Neuroscience Research

Volumn 93, Issue 5, 2015, Pages 815-829

  Wall, Audrey M ^a   Mukandala, Gatambwa ^a   Greig, Nigel H ^b   O'Connor, John J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

1,6 dithiorevlimid; 3,6 dithiothalidomide; CNTO1081; Dentate gyrus; High frequency stimulation; Hypoxia; Interleukin 1 ; Long term potentiation; Prolyl hydroxylase inhibition; Theta burst stimulation; Tumor necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; 2-AMINO-5-PHOSPHOPENTANOIC ACID; IMIDAZOLE DERIVATIVE; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINE DERIVATIVE; VALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; HYPOXIA; LONG TERM POTENTIATION; MALE; NONHUMAN; PERFORANT NERVE TRACT; PLASTICITY; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; ANALOGS AND DERIVATIVES; ANIMAL; ANOXIA; CELL CULTURE; DRUG EFFECTS; ELECTROSTIMULATION; IN VITRO STUDY; METABOLISM; NEWBORN; PATCH CLAMP TECHNIQUE; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; DENTATE GYRUS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; IMIDAZOLES; IN VITRO TECHNIQUES; INTERLEUKIN-1BETA; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; LONG-TERM POTENTIATION; MALE; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; TUMOR NECROSIS FACTOR-ALPHA; VALINE;

EID: 84925598097     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23540     Document Type: Article

References (57)

1. Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS. 2013. TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab 33:1564-1573.
2. Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon JS, Hoffer BJ, Greig NH, Pick CG. 2011. Tumor necrosis factor-α synthesis inhibitor, 3, 6′-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem 118:1032-1042.
3. Batti L, O'Connor JJ. 2010. Tumor necrosis factor-alpha impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices. J Neuroimmunol 218:21-27.
4. Batti L, Taylor CT, O'Connor JJ. 2010. Hydroxylase inhibition reduces synaptic transmission and protects against a glutamate-induced ischemia in the CA1 region of the rat hippocampus. Neurosci 167:1014-1024.
5. Baune BT, Camara M-L, Eyre H, Jawahar C, Anscomb H, Körner H. 2012. Tumour necrosis factor-alpha mediated mechanisms of cognitive dysfunction. Transl Neurosc 3:263-277.
6. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC. 2002. Control of synaptic strength by glial TNFalpha. Science 295:2282-2285.
7. Beitner-Johnson D. 1998. Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism. J Biol Chem 273:19834-19839.
8. Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S. 2012. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflamm 9:23.
9. Bellinger FP, Madamba S, Siggins GR. 1993. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234.
10. Benito E, Barco A. 2010. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci 33:230-240.
11. Boycott HE, Wilkinson J, Boyle JP, Pearson H, Peers C. 2008. Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters. Glia 56:998-1004.
12. Butler MP, O'Connor JJ, Moynagh PN. 2004. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early- but not late-phase LTP. Neuroscience 124:319-326.
13. Carmen J, Rothstein JD, Kerr DA. 2009. Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis. Brain Res 1263:143-154.
14. Coogan AN, O'Connor JJ. 1999. Interleukin-1beta inhibits a tetraethylammonium-induced synaptic potentiation in the rat dentate gyrus in vitro. Eur J Pharmacol 374:197-206.
15. Coogan AN, O'Neill LA, O'Connor JJ. 1999. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93:57-69.
16. Corcoran A, Kunze R, Harney SC, Breier G, Marti HH, O'Connor JJ. 2013. A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity. Hippocampus 872:861-872.
17. Cumiskey D, Butler MP, Moynagh PN, O'Connor JJ. 2007. Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-α on long-term potentiation. Brain Res 1136:13-19.
18. Cunningham AJ, Murray CA, O'Neil LA, Lynch MA, O'Connor JJ. 1996. Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20.
19. Curran BP, Murray HJ, O'Connor JJ. 2003. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neurosci 118:347-357.
20. Dale N, Pearson T, Frenguelli BG. 2000. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J Physiol 526:143-155.
21. Fujita N, Gogate SS, Chiba K, Toyama Y, Shapiro IM, Risbud MV. 2012. Prolyl hydroxylase 3 (PHD3) modulates catabolic effects of tumor necrosis factor-α (TNF-α) on cells of the nucleus pulposus through co-activation of nuclear factor κB (NF-κB)/p65 signaling. J Biol Chem 287:39942-3953.
22. Greig NH, Giordano T, Zhu X, Yu Q, Perry TA, Holloway HW, Brossi A, Rogers JT, Sambamurti K, Lahiri DK. 2004. Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases. Acta Neurobiol Exp 64:1-9.
23. Gruart A, Benito E, Delgado-García JM, Barco A. 2012. Enhanced cAMP response element-binding protein activity increases neuronal excitability, hippocampal long-term potentiation, and classical eyeblink conditioning in alert behaving mice. J Neurosci 32:17431-17441.
24. Haddad JJ. 2005. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol 77:252-282.
25. Hu BR, Fux CM. 1999. Persistent phosphorylation of cyclic AMP responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain. Neuroscience 89:437-452.
26. Huxtable AG, Smith SMC, Vinit S, Watters JJ, Mitchell GS. 2013. Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia. J Appl Physiol 114:879-887.
27. Kass IS, Lipton P. 1986. Calcium and long-term transmission damage following anoxia in dentate gyrus and CA1 regions of the rat. J Physiol 378:313-334.
28. Korn T, Magnus T, Jung S. 2005. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J 19:1878-1880.
29. Kreisman NR, Soliman S, Gozal D. 2000. Regional differences in hypoxic depolarization and swelling in hippocampal slices. J Neurophysiol 83:1031-1038.
30. Larson J, Wong D, Lynch G. 1986. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res 368:347-350.
31. Lin CH, Yeh SH, Lu KT, Leu TH, Chang WC, Gean PW. 2001. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31:841-851.
32. Luo W, Yu QS, Tweedie D, Deschamps J, Parrish D, Holloway HW, Li Y, Brossi A, Greig NH. 2008. Syntheses of aromatic substituted 6′-thiothalidomides. Synthesis 21:3415-3422.
33. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel ULM. 2004. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279:32869-32881.
34. O'Connor JJ 2013. Targeting tumour necrosis factor-α in hypoxia and synaptic signalling. Ir J Med Sci 182:157-162.
35. O'Leary DM, Cassidy EM, O'Connor JJ. 1997. Group II and III metabotropic glutamate receptors modulate paired pulse depression in the rat dentate gyrus in vitro. Eur J Pharmacol 340:35-44.
36. Park EC, Ghose P, Shao Z, Ye Q, Kang L, Xu XZS, Powell-Coffman JA, Rongo C. 2012. Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. EMBO J 31:1379-1393.
37. Pickering M, Cumiskey D, O'Connor JJ. 2005. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663-670.
38. Richter-Levin G, Canevari L, Bliss TVP. 1995. Long-term potentiation and glutamate release in the dentate gyrus: links to spatial learning. Behav Brain Res 66:37-40.
39. Ross FM, Allan SM, Rothwell NJ, Verkhratsky A. 2003. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 144:61-67.
40. Row BW, Liu R, Xu W, Kheirandish L, Gozal D. 2003. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 167:1548-1553.
41. Santello M, Bezzi P, Volterra A. 2011. TNFα controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69:988-1001.
42. Scholz CC, Taylor CT. 2013. Targeting the HIF pathway in inflammation and immunity. Curr Opin Pharmacol 13:646-653.
43. Starke RM, Chalouhi N, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Wada K, Shimada K, Hasan DM, Greig NH, Owens GK, Dumont AS. 2014. Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflamm 11:77.
44. Stellwagen D, Malenka RC. 2006. Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054-1059.
45. Stellwagen D, Beattie EC, Seo JY, Malenka RC. 2005. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219-3228.
46. Tancredi V, D'Arcangelo G, Grassi F. 1992. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146:176-178.
47. Tweedie D, Ferguson RA, Fishman K, Frankola KA, Van Praag H, Holloway HW, Luo W, Li Y, Caracciolo L, Russo I, Barlati S, Ray B, Lahiri DK, Bosetti F, Greig NH, Rosi S. 2012. Tumor necrosis factor-α synthesis inhibitor 3, 6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. J Neuroinflamm 9:106.
48. Vesce S, Rossi D, Brambilla L, Volterra A. 2007. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 82:57-71.
49. Vinit S, Windelborn J a, Mitchell GS. 2011. Lipopolysaccharide attenuates phrenic long-term facilitation following acute intermittent hypoxia. Resp Physiol Neurobiol 176:130-135.
50. Wall AM, Corcoran AE, O'Halloran KD, O'Connor JJ. 2014. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus. Neurobiol Dis 62:8-17.
51. Wang Q, Tang XN, Yenari MA. 2007. The inflammatory response in stroke. J Neuroimmunol 184:53-68.
52. Watters O, O'Connor JJ. 2011. A role for tumor necrosis factor-α in ischemia and ischemic preconditioning. J Neuroinflamm 8:87.
53. Watters O, Pickering M, O'Connor JJ. 2011. Preconditioning effects of tumor necrosis factor-α and glutamate on calcium dynamics in rat organotypic hippocampal cultures. J. Neuroimmunol 234:27-39.
54. Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ. 2009. Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem 109:1237-1249.
55. Yoon JS, Lee J-H, Tweedie D, Mughal MR, Chigurupati S, Greig NH, Mattson MP. 2013. 3, 6′-Dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J Neurosci Res 91:671-680.
56. Zhang J, Malik A, Choi HB, Ko RW, Dissing-Olesen L, MacVicar BA. 2014. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 82:195-207.
57. Zhu X, Giordano T, Yu Q-S, Holloway HW, Perry TA, Lahiri DK, Brossi A, Greig NH. 2003. Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity. J Med Chem 46:5222-5229.